Suppr超能文献

亚临床甲状腺功能减退症与复发性流产患者的甲状腺自身免疫:系统评价和荟萃分析。

Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis.

机构信息

Department of Obstetrics and Gynecology, College of Medicine, University of Illinois, Chicago, Illinois.

Department of Medicine, Obstetrics and Gynecology, and Medical Education, College of Medicine, University of Illinois, Rockford, Illinois.

出版信息

Fertil Steril. 2020 Mar;113(3):587-600.e1. doi: 10.1016/j.fertnstert.2019.11.003.

Abstract

OBJECTIVE

To determine whether overt/subclinical hypothyroidism and/or thyroid autoimmunity is associated with recurrent pregnancy loss (RPL) and whether treatment improves outcomes.

DESIGN

Systematic review and meta-analysis.

SETTING

University obstetrics and gynecology departments.

PATIENT(S): Women with RPL and overt/subclinical hypothyroidism, and/or thyroid autoimmunity.

INTERVENTION(S): None.

MAIN OUTCOME MEASURE(S): Associations between RPL and overt/subclinical hypothyroidism and/or thyroid autoimmunity and any effects of treatment.

RESULT(S): After our review of articles from PubMed, EMBASE, Web of Science, and CENTRAL, we found two interventional studies in which levothyroxine did not improve the subsequent live-birth rate in women with subclinical hypothyroidism with or without thyroid antibodies. A meta-analysis of five studies revealed the prevalence of subclinical hypothyroidism in RPL to be 12.9% (95% confidence interval [CI], 0%-35.2%). A meta-analysis of 17 studies revealed a statistically significant association between RPL and thyroid autoimmunity (odds ratio 1.94; 95% CI, 1.43-2.64). However, a randomized study suggested that levothyroxine does not benefit euthyroid women with thyroid autoimmunity.

CONCLUSION(S): Based on the limited observational studies available, no association exists between RPL and subclinical hypothyroidism, nor does levothyroxine improve subsequent pregnancy outcomes. An association exists between RPL and thyroid autoimmunity, but levothyroxine does not improve subsequent pregnancy outcomes. Women with RPL should be screened/treated for overt thyroid disease but not thyroid autoimmunity. Thyroid antibody screening is not supported by the published studies, and further randomized studies are needed. No recommendation regarding the treatment of subclinical hypothyroidism can be made at this time; prospective and randomized studies are urgently needed.

摘要

目的

确定显性/亚临床甲状腺功能减退症和/或甲状腺自身免疫是否与复发性妊娠丢失(RPL)相关,以及治疗是否改善结局。

设计

系统评价和荟萃分析。

设置

大学妇产科。

患者

RPL 合并显性/亚临床甲状腺功能减退症和/或甲状腺自身免疫的患者。

干预措施

无。

主要观察指标

RPL 与显性/亚临床甲状腺功能减退症和/或甲状腺自身免疫的相关性以及治疗的任何效果。

结果

在对来自 PubMed、EMBASE、Web of Science 和 CENTRAL 的文章进行综述后,我们发现了两项干预性研究,其中左甲状腺素并未改善有或无甲状腺抗体的亚临床甲状腺功能减退症妇女的后续活产率。五项研究的荟萃分析显示,RPL 中亚临床甲状腺功能减退症的患病率为 12.9%(95%置信区间[CI],0%-35.2%)。17 项研究的荟萃分析显示,RPL 与甲状腺自身免疫之间存在统计学显著关联(优势比 1.94;95%CI,1.43-2.64)。然而,一项随机研究表明,左甲状腺素对甲状腺自身免疫的甲状腺功能正常妇女无益。

结论

根据现有的有限观察性研究,RPL 与亚临床甲状腺功能减退症之间没有关联,左甲状腺素也不能改善后续妊娠结局。RPL 与甲状腺自身免疫之间存在关联,但左甲状腺素不能改善后续妊娠结局。RPL 患者应筛查/治疗显性甲状腺疾病,但不应筛查/治疗甲状腺自身免疫。甲状腺抗体筛查没有得到发表研究的支持,需要进一步进行随机研究。目前不能对亚临床甲状腺功能减退症的治疗提出建议;迫切需要进行前瞻性和随机研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验